RhoA and Rac1 GTPases differentially regulate agonist-receptor mediated reactive oxygen species generation in platelets

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Akbar, Huzoor ^a   Duan, Xin ^b   Saleem, Saima ^a,c   Davis, Ashley K ^b   Zheng, Yi ^b  

^a OHIO UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MYOSIN LIGHT CHAIN; PADGEM PROTEIN; PROTEIN P47; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PLATELET SHAPE CHANGE; PLATELET SPREADING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTOPOIESIS;

EID: 84991721119     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163227     Document Type: Article

References (52)

1. Akbar H. Antithrombotic drugs and their complications. In: Pathobiology of Human Disease,. McManus LM, Mitchell RN, editors: Elsevier, doi: 10.1016/B978-0-12-386456-7.07914-4; pp. 1613-1627 (2014).
2. McCarty OJ, Larson MK, Auger JM, Kalia N, Atkinson BT, Pearce AC, et al. Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. The Journal of biological chemistry. 2005; 280(47):39474-84. doi: 10.1074/jbc.M504672200 PMID: 16195235; PubMed Central PMCID: PMC1395485.
3. Aslan JE, Baker SM, Loren CP, Haley KM, Itakura A, Pang J, et al. The PAK system links Rho GTPase signaling to thrombin-mediated platelet activation. American journal of physiology Cell physiology. 2013; 305(5):C519-28. doi: 10.1152/ajpcell.00418.2012 PMID: 23784547; PubMed Central PMCID: PMC3761148.
4. Aslan JE, Itakura A, Haley KM, Tormoen GW, Loren CP, Baker SM, et al. p21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shear. Arteriosclerosis, thrombosis, and vascular biology. 2013; 33(7):1544-51. doi: 10.1161/ATVBAHA.112.301165 PMID: 23640496.
5. Akbar H, Shang X, Perveen R, Berryman M, Funk K, Johnson JF, et al. Gene targeting implicates Cdc42 GTPase in GPVI and non-GPVI mediated platelet filopodia formation, secretion and aggregation. PloS one. 2011; 6(7):e22117. doi: 10.1371/journal.pone.0022117 PMID: 21789221; PubMed Central PMCID: PMC3138762.
6. Shen B, Delaney MK, Du X. Inside-out, outside-in, and inside-outside-in: G protein signaling in integrin-mediated cell adhesion, spreading, and retraction. Current opinion in cell biology. 2012; 24(5):600-6. doi: 10.1016/j.ceb.2012.08.011 PMID: 22980731; PubMed Central PMCID: PMC3479359.
7. Flevaris P, Li Z, Zhang G, Zheng Y, Liu J, Du X. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood. 2009; 113(4):893-901. doi: 10.1182/blood-2008-05-155978 PMID: 18957688; PubMed Central PMCID: PMC2630274.
8. Akbar H, Kim J, Funk K, Cancelas JA, Shang X, Chen L, et al. Genetic and pharmacologic evidence that Rac1 GTPase is involved in regulation of platelet secretion and aggregation. Journal of thrombosis and haemostasis: JTH. 2007; 5(8):1747-55. doi: 10.1111/j.1538-7836.2007.02646.x PMID: 17663742.
9. Pandey D, Goyal P, Dwivedi S, Siess W. Unraveling a novel Rac1-mediated signaling pathway that regulates cofilin dephosphorylation and secretion in thrombin-stimulated platelets. Blood. 2009; 114(2):415-24. doi: 10.1182/blood-2008-10-183582 PMID: 19429871.
10. Dwivedi S, Pandey D, Khandoga AL, Brandl R, Siess W. Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque. Journal of translational medicine. 2010; 8:128. doi: 10.1186/1479-5876-8-128 PMID: 21134286; PubMed Central PMCID: PMC3018435.
11. Goggs R, Harper MT, Pope RJ, Savage JS, Williams CM, Mundell SJ, et al. RhoG protein regulates platelet granule secretion and thrombus formation in mice. The Journal of biological chemistry. 2013; 288(47):34217-29. doi: 10.1074/jbc.M113.504100 PMID: 24106270; PubMed Central PMCID: PMC3837162.
12. Kim S, Dangelmaier C, Bhavanasi D, Meng S, Wang H, Goldfinger LE, et al. RhoG protein regulates glycoprotein VI-Fc receptor gamma-chain complex-mediated platelet activation and thrombus formation. The Journal of biological chemistry. 2013; 288(47):34230-8. doi: 10.1074/jbc.M113.504928 PMID: 24106269; PubMed Central PMCID: PMC3837163.
13. Akbar H, Cancelas J, Williams DA, Zheng J, Zheng Y. Rational design and applications of a Rac GTPase-specific small molecule inhibitor. Methods in enzymology. 2006; 406:554-65. doi: 10.1016/S0076-6879(06)06043-5 PMID: 16472687.
14. Krotz F, Sohn HY, Pohl U. Reactive oxygen species: players in the platelet game. Arteriosclerosis, thrombosis, and vascular biology. 2004; 24(11):1988-96. doi: 10.1161/01.ATV.0000145574.90840.7d PMID: 15374851.
15. Violi F, Pignatelli P. Platelet NOX, a novel target for anti-thrombotic treatment. Thrombosis and haemostasis. 2014; 111(5):817-23. doi: 10.1160/TH13-10-0818 PMID: 24402688.
16. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological reviews. 2007; 87(1):245-313. doi: 10.1152/physrev.00044.2005 PMID: 17237347.
17. Vara D, Campanella M, Pula G. The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner. British journal of pharmacology. 2013; 168(1):212-24. doi: 10.1111/j.1476-5381.2012.02130.x PMID: 22881838; PubMed Central PMCID: PMC3570016.
18. Delaney MK, Kim K, Estevez B, Xu Z, Stojanovic-Terpo A, Shen B, et al. Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis. Arteriosclerosis, thrombosis, and vascular biology. 2016; 36(5):846-54. doi: 10.1161/ATVBAHA.116.307308 PMID: 26988594; PubMed Central PMCID: PMC4850088.
19. Bakdash N, Williams MS. Spatially distinct production of reactive oxygen species regulates platelet activation. Free radical biology & medicine. 2008; 45(2):158-66. doi: 10.1016/j.freeradbiomed.2008.03.021 PMID: 18452718.
20. Begonja AJ, Gambaryan S, Geiger J, Aktas B, Pozgajova M, Nieswandt B, et al. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood. 2005; 106(8):2757-60. doi: 10.1182/blood-2005-03-1047 PMID: 15976180.
21. Arthur JF, Qiao J, Shen Y, Davis AK, Dunne E, Berndt MC, et al. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. Journal of thrombosis and haemostasis: JTH. 2012; 10(6):1133-41. doi: 10.1111/j.1538-7836.2012.04734.x PMID: 22489915.
22. Kim JS, Kim JG, Jeon CY, Won HY, Moon MY, Seo JY, et al. Downstream components of RhoA required for signal pathway of superoxide formation during phagocytosis of serum opsonized zymosans in macrophages. Experimental & molecular medicine. 2005; 37(6):575-87. doi: 10.1038/emm.2005.71 PMID: 16391519.
23. Matono R, Miyano K, Kiyohara T, Sumimoto H. Arachidonic acid induces direct interaction of the p67 (phox)-Rac complex with the phagocyte oxidase Nox2, leading to superoxide production. The Journal of biological chemistry. 2014; 289(36):24874-84. doi: 10.1074/jbc.M114.581785 PMID: 25056956; PubMed Central PMCID: PMC4155656.
24. Miyano K, Sumimoto H. Assessment of the role for Rho family GTPases in NADPH oxidase activation. Methods in molecular biology. 2012; 827:195-212. doi: 10.1007/978-1-61779-442-1-14 PMID: 22144277.
25. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circulation research. 2006; 99(12):1293-304. doi: 10.1161/01.RES.0000251742.71301.16 PMID: 17158345.
26. Aghajanian A, Wittchen ES, Campbell SL, Burridge K. Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PloS one. 2009; 4(11):e8045. doi: 10.1371/journal.pone.0008045 PMID: 19956681; PubMed Central PMCID: PMC2778012.
27. Klages B, Brandt U, Simon MI, Schultz G, Offermanns S. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. The Journal of cell biology. 1999; 144(4):745-54. PMID: 10037795; PubMed Central PMCID: PMC2132941.
28. Shang X, Marchioni F, Sipes N, Evelyn CR, Jerabek-Willemsen M, Duhr S, et al. Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases. Chemistry & biology. 2012; 19(6):699-710. doi: 10.1016/j.chembiol.2012.05.009 PMID: 22726684; PubMed Central PMCID: PMC3383629.
29. Zhou X, Florian MC, Arumugam P, Chen X, Cancelas JA, Lang R, et al. RhoA GTPase controls cytokinesis and programmed necrosis of hematopoietic progenitors. The Journal of experimental medicine. 2013; 210(11):2371-85. doi: 10.1084/jem.20122348 PMID: 24101377; PubMed Central PMCID: PMC3804933.
30. Cancelas JA, Lee AW, Prabhakar R, Stringer KF, Zheng Y, Williams DA. Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nature medicine. 2005; 11(8):886-91. doi: 10.1038/nm1274 PMID: 16025125.
31. Perveen R, Funk K, Thuma J, Wulf Ridge S, Cao Y, Akkerman JW, et al. A novel small molecule 1,2,3PloS one. 2011; 6(11):e26238. doi: 10.1371/journal.pone.0026238 PMID: 22073153; PubMed Central PMCID: PMC3206812.
32. Liu W, Feng Y, Shang X, Zheng Y. Rho GTPases in hematopoietic stem/progenitor cell migration. Methods in molecular biology. 2011; 750:307-19. doi: 10.1007/978-1-61779-145-1-21 PMID: 21618100.
33. Bosco EE, Kumar S, Marchioni F, Biesiada J, Kordos M, Szczur K, et al. Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation. Chemistry & biology. 2012; 19(2):228-42. doi: 10.1016/j.chembiol.2011.12.017 PMID: 22365606; PubMed Central PMCID: PMC3292765.
34. Suzuki Y, Yamamoto M, Wada H, Ito M, Nakano T, Sasaki Y, et al. Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase. Blood. 1999; 93(10):3408-17. PMID: 10233893.
35. Pleines I, Hagedorn I, Gupta S, May F, Chakarova L, van Hengel J, et al. Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis. Blood. 2012; 119(4):1054-63. doi: 10.1182/blood-2011-08-372193 PMID: 22045984.
36. Nishioka H, Horiuchi H, Tabuchi A, Yoshioka A, Shirakawa R, Kita T. Small GTPase Rho regulates thrombin-induced platelet aggregation. Biochemical and biophysical research communications. 2001; 280(4):970-5. doi: 10.1006/bbrc.2001.4237 PMID: 11162620.
37. Bodie SL, Ford I, Greaves M, Nixon GF. Thrombin-induced activation of RhoA in platelet shape change. Biochemical and biophysical research communications. 2001; 287(1):71-6. doi: 10.1006/bbrc.2001.5547 PMID: 11549255.
38. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(20):7618-23. doi: 10.1073/pnas.0307512101 PMID: 15128949; PubMed Central PMCID: PMC419655.
39. Groemping Y, Rittinger K. Activation and assembly of the NADPH oxidase: a structural perspective. The Biochemical journal. 2005; 386(Pt 3):401-16. doi: 10.1042/BJ20041835 PMID: 15588255; PubMed Central PMCID: PMC1134858.
40. Diebold BA, Bokoch GM. Molecular basis for Rac2 regulation of phagocyte NADPH oxidase. Nature immunology. 2001; 2(3):211-5. doi: 10.1038/85259 PMID: 11224519.
41. Lapouge K, Smith SJ, Walker PA, Gamblin SJ, Smerdon SJ, Rittinger K. Structure of the TPR domain of p67phox in complex with Rac.GTP. Molecular cell. 2000; 6(4):899-907. PMID: 11090627.
42. Handin RI, Karabin R, Boxer GJ. Enhancement of platelet function by superoxide anion. The Journal of clinical investigation. 1977; 59(5):959-65. doi: 10.1172/JCI108718 PMID: 192766; PubMed Central PMCID: PMC372304.
43. Marcus AJ, Silk ST, Safier LB, Ullman HL. Superoxide production and reducing activity in human platelets. The Journal of clinical investigation. 1977; 59(1):149-58. doi: 10.1172/JCI108613 PMID: 187622; PubMed Central PMCID: PMC333342.
44. Seno T, Inoue N, Gao D, Okuda M, Sumi Y, Matsui K, et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thrombosis research. 2001; 103(5):399-409. PMID: 11553372.
45. Chlopicki S, Olszanecki R, Janiszewski M, Laurindo FR, Panz T, Miedzobrodzki J. Functional role of NADPH oxidase in activation of platelets. Antioxidants & redox signaling. 2004; 6(4):691-8. doi: 10.1089/1523086041361640 PMID: 15242549.
46. Begonja AJ, Teichmann L, Geiger J, Gambaryan S, Walter U. Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS. Blood cells, molecules & diseases. 2006; 36(2):166-70. doi: 10.1016/j.bcmd.2005.12.028 PMID: 16469512.
47. Pignatelli P, Carnevale R, Di Santo S, Bartimoccia S, Sanguigni V, Lenti L, et al. Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction. Arteriosclerosis, thrombosis, and vascular biology. 2011; 31(2):423-34. doi: 10.1161/ATVBAHA.110.217885 PMID: 21071703.
48. Getz TM, Dangelmaier CA, Jin J, Daniel JL, Kunapuli SP. Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets. Journal of thrombosis and haemostasis: JTH. 2010; 8(10):2283-93. doi: 10.1111/j.1538-7836.2010.04000.x PMID: 20670370; PubMed Central PMCID: PMC2965805.
49. Leng L, Kashiwagi H, Ren XD, Shattil SJ. RhoA and the function of platelet integrin alphaIIbbeta3. Blood. 1998; 91(11):4206-15. PMID: 9596668.
50. Gao G, Chen L, Dong B, Gu H, Dong H, Pan Y, et al. RhoA effector mDia1 is required for PI 3-kinase-dependent actin remodeling and spreading by thrombin in platelets. Biochemical and biophysical research communications. 2009; 385(3):439-44. doi: 10.1016/j.bbrc.2009.05.090 PMID: 19470376.
51. Gong H, Shen B, Flevaris P, Chow C, Lam SC, Voyno-Yasenetskaya TA, et al. G protein subunit Galpha13 binds to integrin alphaIIbbeta3 and mediates integrin "outside-in" signaling. Science. 2010; 327(5963):340-3. doi: 10.1126/science.1174779 PMID: 20075254; PubMed Central PMCID: PMC2842917.
52. Jirouskova M, Jaiswal JK, Coller BS. Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading. Blood. 2007; 109(12):5260-9. doi: 10.1182/blood-2006-10-054015 PMID: 17332246; PubMed Central PMCID: PMC1890822.